Triphenylphosphonium-functionalized dimeric BODIPY-based nanoparticles for mitochondria-targeting photodynamic therapy
Chanwoo Kim,Duy Khuong Mai,Joomin Lee,Jinwoong Jo,Soyeon Kim,Isabel Wen Badon,Jong Min Lim,Ho-Joong Kim,Jaesung Yang
DOI: https://doi.org/10.1039/d4nr00694a
IF: 6.7
2024-04-20
Nanoscale
Abstract:The dimerization of boron dipyrromethene (BODIPY) moieties is an appealing molecular design approach for developing heavy-atom-free triplet photosensitizers (PSs). However, BODIPY dimer-based PSs generally lack target specificity, which limits their clinical use for photodynamic therapy. This study reports the synthesis of two mitochondria-targeting triphenylphosphonium (TPP)-functionalized meso–β directly linked BODIPY dimers ( BTPP and BeTPP ). Both BODIPY dimers exhibited solvent-polarity-dependent singlet oxygen ( 1 O 2 ) quantum yields, with maximum values of 0.84 and 0.55 for BTPP and BeTPP , respectively, in tetrahydrofuran. The compact orthogonal geometry of the BODIPY dimers facilitated the generation of triplet excited states via photoinduced charge separation (CS) and subsequent spin–orbit charge-transfer intersystem crossing (SOCT-ISC) processes and their rates were dependent on the energetic configuration between the frontier molecular orbitals of the two BODIPY subunits. The as-synthesized compounds were amphiphilic and hence formed stable nanoparticles (∼36 nm in diameter) in aqueous solutions, with a zeta potential of ∼33 mV beneficial for mitochondrial targeting. In vitro experiments with MCF-7 and HeLa cancer cells indicated the effective localization of BTPP and BeTPP within cancer-cell mitochondria. Under light irradiation, BTPP and BeTPP exhibited robust photo-induced therapeutic effects in both cell lines, with half-maximal inhibitory concentration (IC 50 ) values of ∼30 and ∼55 nM, respectively.
materials science, multidisciplinary,physics, applied,nanoscience & nanotechnology,chemistry